1st line chemotherapy and contribution of bevacizumab and impact of second-line chemotherapy in unselected patients

Date 15 December 2015
Event ESMO Preceptorship on NSCLC, Singapore
Session Session 4 - Metastatic NSCLC
Topics Non-Small-Cell Lung Cancer, Metastatic
Anti-Cancer Agents & Biologic Therapy
Presenter F. Cappuzzo, IT